Diphen and Amifostine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diphen (diphenhydramine hydrochloride) and Amifostine (amifostine). Common drug interactions include gastroenteritis among females and bone marrow failure among males.

The phase IV clinical study analyzes what interactions people have when they take Diphen and Amifostine. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Diphen?

Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.

What is Amifostine?

Amifostine has active ingredients of amifostine. eHealthMe is studying from 425 Amifostine users. Check the latest studies of Amifostine.



On Jul, 12, 2026

23 people who take Diphen and Amifostine together, and have interactions are studied.

Diphen and Amifostine drug interactions.

What are the common drug interactions of Diphen and Amifostine, by gender? *:

female:

  1. Gastroenteritis (inflammation of stomach and intestine)
  2. Chest discomfort
  3. Dyspnoea (difficult or laboured respiration)
  4. Anaemia (lack of blood)
  5. Anaphylactic reaction (serious allergic reaction)
  6. Anorectal infection
  7. Constipation
  8. Gasping (laboured breathing)
  9. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  10. Platelet count decreased

male:

  1. Bone marrow failure
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  4. Mucosal inflammation (infection of mucous membrane)
  5. Sweating increased (excess sweating)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Lung infection
  8. Ventricular extrasystoles (premature cardiac contraction)
  9. Abdominal pain
  10. Arrhythmia (irregular heartbeat)

What are the common drug interactions of Diphen and Amifostine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Gastroenteritis (inflammation of stomach and intestine)
  2. Dyspnoea (difficult or laboured respiration)
  3. Flushing (the warm, red condition of human skin)
  4. Abdominal pain
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Mucosal inflammation (infection of mucous membrane)
  7. Sweating increased (excess sweating)
  8. Vomiting

50-59:

  1. Chest discomfort
  2. Anaphylactic reaction (serious allergic reaction)
  3. Dyspnoea (difficult or laboured respiration)
  4. Gasping (laboured breathing)
  5. Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
  6. Burning sensation
  7. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  8. Chest pain
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Hypersensitivity

60+:

  1. Bone marrow failure
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Myelosuppression (a decrease in the production of blood cells)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. White blood cell count decreased
  7. Anaemia (lack of blood)
  8. Anorectal infection
  9. Constipation
  10. Haemorrhoids (a swollen vein or group of veins in the region of the anus)

What are the existing conditions these people have? *

  1. Reduction Of Increased Intracranial Pressure (reducing intracranial pressure): 3 people, 13.04%
  2. Urination - Excessive Volume: 2 people, 8.70%
  3. Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 2 people, 8.70%
  4. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 8.70%
  5. Leukopenia (less number of white blood cells in blood): 2 people, 8.70%
  6. Hypoaesthesia (reduced sense of touch or sensation): 2 people, 8.70%
  7. High Blood Pressure: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Diphen and Amifostine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diphen and Amifostine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amifostine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diphen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amifostine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and amifostine (the active ingredients of Diphen and Amifostine, respectively), and Diphen and Amifostine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: